NasdaqCM - Delayed Quote USD

SeaStar Medical Holding Corporation (ICU)

1.2700
+0.0780
+(6.54%)
At close: June 6 at 4:00:00 PM EDT
1.2312
-0.04
(-3.06%)
After hours: June 6 at 6:49:33 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
428
135
0
0
0
Cost of Revenue
0
0
0
--
--
Gross Profit
428
135
0
--
--
Operating Expense
18,142
17,977
14,210
11,609
4,449
Operating Income
-17,714
-17,842
-14,210
-11,609
-4,449
Net Non Operating Interest Income Expense
37
-143
-1,081
-630
-212
Other Income Expense
1,778
-6,842
-10,941
50
64
Pretax Income
-15,899
-24,827
-26,232
-12,189
-4,597
Tax Provision
6
3
0
1
-1
Net Income Common Stockholders
-15,905
-24,830
-26,232
-12,190
-4,596
Diluted NI Available to Com Stockholders
-15,905
-24,830
-26,232
-12,190
-4,596
Basic EPS
-2.34
-6.63
-30.26
-70.00
-9.05
Diluted EPS
-2.34
-6.63
-30.26
-70.00
-9.05
Basic Average Shares
5,226.9760
3,743.5540
866.8130
328.4500
507.9860
Diluted Average Shares
5,226.9760
3,743.5540
866.8130
328.4500
507.9860
Total Operating Income as Reported
-17,714
-17,842
-14,210
-11,609
-4,449
Total Expenses
18,142
17,977
14,210
11,609
4,449
Net Income from Continuing & Discontinued Operation
-15,905
-24,830
-26,232
-12,190
-4,596
Normalized Income
-22,164.1700
-24,133
-20,520
-12,240
-4,569
Interest Income
149
101
0
--
--
Interest Expense
112
244
1,081
630
212
Net Interest Income
37
-143
-1,081
-630
-212
EBIT
-15,787
-24,583
-25,151
-11,559
-4,385
EBITDA
-15,787
-24,583
-25,151
-11,559
-4,385
Reconciled Cost of Revenue
0
0
0
--
--
Net Income from Continuing Operation Net Minority Interest
-15,905
-24,830
-26,232
-12,190
-4,596
Total Unusual Items Excluding Goodwill
7,923
-697
-5,712
50
-27
Total Unusual Items
7,923
-697
-5,712
50
-27
Normalized EBITDA
-23,710
-23,886
-19,439
-11,609
-4,358
Tax Rate for Calcs
0.0002
0
0
0
0
Tax Effect of Unusual Items
1,663.8300
0
0
0
0
12/31/2021 - 3/18/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SLS SELLAS Life Sciences Group, Inc.
1.6100
-1.23%
 
ENSC Ensysce Biosciences, Inc.
2.3800
+1.71%
 
CDIO Cardio Diagnostics Holdings, Inc.
4.7650
+5.42%
 
ZVSA ZyVersa Therapeutics, Inc.
0.6549
+1.50%
 
AVTX Avalo Therapeutics, Inc.
4.1000
-5.31%
 
ABVC ABVC BioPharma, Inc.
1.5400
+2.67%
 
QNRX Quoin Pharmaceuticals, Ltd.
8.82
+0.74%
 
PBM Psyence Biomedical Ltd.
5.52
+8.23%
 
SPRC SciSparc Ltd.
0.3120
-1.89%
 
XLO Xilio Therapeutics, Inc.
0.7000
+3.20%